Rise Therapeutics
PrivateLast Round
Grant
Dec 15, 2025
Total Funding Raised
$4.78M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rise Therapeutics operates in Healthcare & Life Sciences and is based in Rockville, Maryland. Its latest recorded funding round was a Grant round in December 2025.
Rise Therapeutics is a biotechnology company that develops synthetic biology-based oral immunotherapies for the treatment of autoimmune diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rise Therapeutics Comparables
Compare Rise Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorriso Therapeutics | 78% | |
| Enterome | 76% | |
| Artizan Biosciences | 73% |
For institutional investors. Book with your work email.
Rise Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 15, 2025 | ||||
| Grant | Oct 22, 2025 | ||||
| Grant | Sep 23, 2025 | ||||
| Grant | Oct 22, 2024 | ||||
| Grant | Sep 4, 2023 | ||||
Seed | May 8, 2023 |
For institutional investors. Book with your work email.
Rise Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| TEDCO | Grant, Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 224% MoM, reaching 2.4K.
- Jan 5, 2026
Monthly visitors increased 50% MoM.
For institutional investors. Book with your work email.
Rise Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rise Therapeutics's valuation, stock price, and market status.
Is Rise Therapeutics a public or private company?
Rise Therapeutics is a private company.
What is the current stock price of Rise Therapeutics?
Rise Therapeutics is a private company, so its shares have no public market price. Caplight tracks Rise Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rise Therapeutics worth (valuation)?
Valuation information for Rise Therapeutics is not publicly available.
Can I buy Rise Therapeutics stock?
Rise Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rise Therapeutics's last funding round?
Rise Therapeutics's most recent funding round was Grant on December 15, 2025.
Who are the main investors in Rise Therapeutics?
Key investors in Rise Therapeutics include NIH RADx, TEDCO, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Dental and Craniofacial Research.
Will Rise Therapeutics IPO soon?
No public IPO plans have been announced for Rise Therapeutics.
How can I track Rise Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Rise Therapeutics's shares on secondary markets.